Northwestern’s SPORE has made advances in understanding the genetic basis of glioblastoma

By | October 3, 2021
Glioblastoma is one of the deadliest cancers known to man. While the advent of immunotherapy and other cutting-edge treatments have prolonged life for people afflicted with other types of cancer, the prognosis for glioblastoma has remained relatively constant: just 18 months.